Monday, December 24, 2007 2:23:43 AM
As part of the partnership, DNAPrint will analyze the 600,000 human samples in the Global Repository using the ANCESTRYbyDNA test. According to Richard Gabriel, the CEO and President of DNAPrint Genomics:
“By removing the question of ancestry from a clinical sample researchers can more readily evaluate which medicines will produce side effects within certain ethnic groups, and which medicines will work for the widest spectrum of a population.”
The CEO of BioServe, Dr. Kevin Krenitsky, stated in the press release that “now that we are able to add the genetic ancestry component to our samples, a new layer of sample data quality and analysis can be provided that was not previously available to researchers.”
An order of 600,000 ANCESTRYbyDNA tests will be quite a boon for DNAPrint Genomics, which has been actively seeking markets other than traditional genetic genealogy consumers. And it is possible that this initiative will create a demand for this type of data in many more studies of biological samples.
http://www.thegeneticgenealogist.com/2007/10/18/dnaprint-and-bioserve-600000-genetic-genealogy-tests/
Success is the sum of small efforts, repeated day in and day out.
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM